Methods of optimizing drug therapeutic efficacy for treatment of immune-mediated gastrointestinal disorders
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Dec 1, 2009
Grant Date -
Jul 10, 2008
app pub date -
Aug 20, 2007
filing date -
Sep 24, 1998
priority date (Note) -
In Force
status (Latency Note)
Importance
Abstract
The present invention provides a method of optimizing therapeutic efficacy and reducing toxicity associated with 6-mercaptopurine drug treatment of an immune-mediated gastrointestinal disorder such as inflammatory bowel disease. The method of the invention includes the step of determining the level of one or more 6-mercaptopurine metabolites in the patient having an immune-mediated gastrointestinal disorder.
First Claim
Family
International Classification(s)
- [Classification Symbol]
- [Patents Count]
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully